Who’s Really Writing Your Online Prescription?
You order a prescription online and it arrives in days. Some of it is real care. Some is a sales funnel in a white coat. Here is how to tell the difference.
You order a prescription online and it arrives in days. Some of it is real care. Some is a sales funnel in a white coat. Here is how to tell the difference.
I take tirzepatide. So when the headline came through this week that GLP-1 drugs might slow the spread of cancer, it intrigued me more than most drug news. This is the medication in my own refrigerator. I went and read the actual study instead of the headline, and the short version is that the signal
I’m 53 years old and 170 pounds lighter than I was a year and a half ago. That’s the number everyone asks about. It’s also the wrong number. The number that actually tells the story is one the bathroom scale never showed me. Over one six-month stretch, the scale said I’d lost 35 pounds. The
I’m on Zepbound at a normal dose, the kind a doctor prescribes and a pharmacy fills. A reader sent me a video this week that’s a good way into a question I keep getting asked. In it, the New Zealand GP Brad Stanfield, who runs an evidence-minded health channel, explains that he injects 1.25 milligrams
The CVS Caremark deal just moved a trillion-dollar stock. Here is how Americans actually get Zepbound and Mounjaro across the five channels, who really decides, and what each one costs in 2026.
The first two oral GLP-1 pills are here. A head-to-head on the real weight-loss numbers, daily routine, manufacturing, cost, and who each one actually fits.
People on tirzepatide ask if brenipatide is the upgrade. People reading about brenipatide ask how it compares to the drug everyone is already on. Same class. Very different jobs. A head-to-head comparison.
I’m 170 pounds down on tirzepatide. The most-asked question I get now is ‘is it keto?’ It wasn’t. A 50-something dad untangles what keto, carnivore, low-carb, Mediterranean, and DASH actually are — and what the evidence says about each.
Lilly’s retatrutide just delivered bariatric-equivalent weight loss in Phase 3. The numbers, why the low dose is the real story, and the gray-market reality that got there first.
I am at goal weight on Zepbound. SURMOUNT-MAINTAIN is the trial I have been waiting for. Here is what holding the line at a lower dose actually looks like.